206555-66-0

Basic information

• Product Name: 1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE
• Synonyms: IFLAB-BB F0147-0127;1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE;1-(2-Amino-4-phenyl-1,3-thiazol-5-yl)ethanone;1-(2-amino-4-phenylthiazol-5-yl)ethan-1-one
• CAS NO: 206555-66-0
• Molecular Formula: C11H10N2OS
• Molecular Weight: 218.27
• Mol File: 206555-66-0.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE(206555-66-0)
• EPA Substance Registry System: 1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE(206555-66-0)

Safety Data

• Hazardous Substances Data: 206555-66-0(Hazardous Substances Data)

Usage

General Description

1-(2-amino-4-phenyl-thiazol-5-yl)-ethanone is a chemical compound with the molecular formula C11H10N2OS. It is a thiazole derivative that contains an amino group and a phenyl group attached to the thiazole ring. 1-(2-AMINO-4-PHENYL-THIAZOL-5-YL)-ETHANONE is used in organic synthesis and medicinal chemistry, and it may have potential pharmaceutical applications due to its structural features. It is important to handle this chemical with care and follow proper safety protocols when working with it in a laboratory setting.

Upstream product

• 1361413-53-7 N-(bis(4-methoxybenzyl)carbamothioyl)benzamide 
• 17356-08-0 thiourea 
• 93-91-4 1-phenylbutan-1,3-dione 

Relevant articles and documents

Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays

Cystic fibrosis (CF) is the autosomal recessive disorder most recurrent in Caucasian populations. It is caused by different mutations in the cystic fibrosis transmembrane regulator protein (CFTR) gene, with F508del being the most common. During the last y

Method for synthesizing 2-aminothiazole derivative

The invention discloses a method for synthesizing a 2-aminothiazole derivative. The method comprises the following steps: by taking a ketone derivative (I) with an electron withdrawing group at the alpha position and thiourea (II) as raw materials, t-buty

NF-KB ACTIVATION INHIBITORS

A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein A represents hydrogen atom or acetyl group, E represents a 2,5-di-substituted or a 3,5-di-substituted phenyl group, or a monocyclic or a fused polycyclic heteroaryl group which may be substituted, provided that the compound wherein said heteroaryl group is 1○ a fused polycyclic heteroaryl group wherein the ring which binds directly to ―CONH― group in the formula (I) is a benzene ring, 2○ unsubstituted thiazol-2-yl group, or 3○ unsubstituted benzothiazol-2-yl group is excluded, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula ―O―A wherein A has the same meaning as that defined above and the group represented by formula -CONH-E wherein E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula ―O―A wherein A has the same meaning as that defined above and the group represented by formula ― CONH―E wherein E has the same meaning as that defined above.